Specialized testing
Delivering value beyond the test result
Our commitment to improving patient outcomes propels the development of clinically impactful, patient-focused testing. Supported by clinical physicians and laboratory scientists with unmatched experience and expertise, our assays — several of which are unavailable elsewhere — deliver actionable answers that improve patient lives.
Our data-driven, evidence-based tests provide actionable answers for patients that clarify each patient’s unique healthcare journey.
Specialty testing menu
Collaborations that power innovation
We relentlessly innovate on behalf of patients to build tests of the future to help physicians impact more lives. Mayo Clinic Laboratories scientists and physicians are leaders in their fields and at the forefront of translating new ideas into meaningful solutions. Through groundbreaking collaborations with healthcare companies and diagnostics leaders, we simplify access to new and advanced laboratory tests.
Commitment to education
The exchange of knowledge is a founding principle at Mayo Clinic. In this tradition, we provide a wide range of education offerings and outreach consultation to help you drive continual improvement.
- Regionally based clinical specialists help guide best practices through physician education.
- Access to Mayo Clinic Laboratories' education offerings and Insight articles.
- Many courses offer CME credits.
- Online trainings are available, such as “Dangerous Goods Shipping,” and include printable certificates.
News and updates
The latest
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss a new collaboration and a Mayo Clinic-led study focused on detecting DNA mutations. Later, Dr. Pritt welcomes Andrew McKeon, M.B., B.Ch., M.D., and Anastasia Zekeridou, M.D., Ph.D., co-directors of Mayo Clinic’s Neuroimmunology Laboratory, to discuss how they are advancing patient care.
John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S., explain how Mayo Clinic Laboratories' new test panel can distinguish among various potential causes of demyelinating neuropathies. Test results are important for managing these devastating autoimmune conditions.
Aiming to advance understanding of hard-to-predict gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Thermo Fisher Scientific joined forces with Mayo Clinic and BioPharma Diagnostics to validate and gain U.S. regulatory clearance of a novel, automated assay aimed at detecting a biomarker associated with the progressive disease.
Learn from Mayo Clinic experts in September's Pathways Case Studies.
In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by special guests Bernard Rubin, D.O., MPH, chief medical officer of Progentec Diagnostics, and Melissa Munroe, M.D., Ph.D., chief scientific officer and principal investigator of Progentec Diagnostics. They discuss Mayo Clinic Laboratories’ suite of innovative lupus testing, offered in collaboration with Progentec Diagnostics, for patients affected by systemic lupus erythematosus (SLE).
Tropical Storm Francine is active in the Gulf of Mexico and is expected to develop into a hurricane. These weather conditions may impact areas in the United States, including Alabama, Arkansas, Louisiana, Mississippi, Tennessee, and Texas. We continue to monitor and track the situation with our logistics partners to minimize challenges. Clients in the impacted areas should expect to be contacted directly if any routes are modified or canceled.
Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' unique genetic tests identify patients at high risk of severe reactions to fluoropyrimidines — a type of chemotherapy drug. Test results can guide clinical decision-making for safer cancer treatment.
This month’s microlearning discusses the various types of customers a laboratory encounters and explains the importance of creating green dot experiences for them.
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., interviews Ewa Wysokinska, M.D., an assistant professor of medicine and consultant in the division of hematology and oncology at Mayo Clinic in Florida, to talk about clinical updates in thrombotic thrombocytopenic purpura.
This page lists updates posted to Mayo Clinic Labs during the month of August.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the latest advancements in Alzheimer’s disease testing and treatment.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They cover current trends, pain points, and opportunities for growth in the lab and diagnostics market.
William Morice II, M.D., Ph.D., recently joined the Advisory Board for a webinar discussion on 2024 lab market trends. Dr. Morice covered the current lab market outlook, the priority trends, and opportunities for future growth.